Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-02-13 5:26 pm Purchase | 2023-12-31 | 13G | Mereo BioPharma Group plc MREO | Suvretta Capital Management, LLC | 36,854,190 5.300% | 32,000![]() (+0.09%) | Filing History |
2024-02-06 4:15 pm Purchase | 2023-12-31 | 13G | Mereo BioPharma Group plc MREO | Soleus Private Equity Fund III, L.P. | 48,887,095 7.000% | 500,000![]() (+1.03%) | Filing History |
2024-02-05 5:09 pm Purchase | 2024-01-24 | 13G | Mereo BioPharma Group plc MREO | ADAGE CAPITAL PARTNERS GP L.L.C. | 50,250,000 7.170% | 50,250,000![]() (New Position) | Filing History |
2023-11-20 08:45 am Purchase | 2023-11-16 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 99,704,885 14.220% | 2,378,330![]() (+2.44%) | Filing History |
2023-11-15 07:56 am Purchase | 2023-11-13 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 97,326,555 13.880% | 7,200![]() (+0.01%) | Filing History |
2023-11-13 07:31 am Purchase | 2023-11-09 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 97,319,355 13.880% | 1,758,195![]() (+1.84%) | Filing History |
2023-11-08 07:06 am Purchase | 2023-11-06 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 95,561,160 13.630% | 2,188,575![]() (+2.34%) | Filing History |
2023-11-06 07:30 am Purchase | 2023-11-03 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 93,372,585 13.320% | 1,081,380![]() (+1.17%) | Filing History |
2023-11-02 07:30 am Purchase | 2023-10-31 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 92,291,205 13.250% | 92,130![]() (+0.10%) | Filing History |
2023-10-30 6:02 pm Purchase | 2023-10-27 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 92,199,075 13.150% | 2,168,475![]() (+2.41%) | Filing History |
2023-08-10 4:42 pm Sale | 2023-07-31 | 13G | Mereo BioPharma Group plc MREO | Baker Bros. Advisors LP | 14,604,391 2.200% | -54,754,968![]() (-78.94%) | Filing History |
2023-07-26 4:31 pm Purchase | 2023-07-24 | 13G | Mereo BioPharma Group plc MREO | Soleus Private Equity Fund III, L.P. | 48,387,095 7.500% | 48,387,095![]() (New Position) | Filing History |
2023-06-16 08:00 am Purchase | 2023-06-14 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 90,030,600 14.410% | 6,250,000![]() (+7.46%) | Filing History |
2023-02-14 4:40 pm Purchase | 2022-12-31 | 13G | Mereo BioPharma Group plc MREO | ORBIMED ADVISORS LLC | 10,378,591 5.920% | 4,315,246![]() (+71.17%) | Filing History |
2023-02-14 4:03 pm Sale | 2022-12-31 | 13G | Mereo BioPharma Group plc MREO | Point72 Asset Management, L.P. | 22 0.100% | -10,609,978![]() (-100.00%) | Filing History |
2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Mereo BioPharma Group plc MREO | Baker Bros. Advisors LP | 69,359,359 9.990% | 4,441,758![]() (+6.84%) | Filing History |
2023-02-14 2:55 pm Purchase | 2022-12-31 | 13G | Mereo BioPharma Group plc MREO | Rock Springs Capital Management LP | 31,224,485 5.340% | 25,638,864![]() (+459.02%) | Filing History |
2023-02-13 5:48 pm Sale | 2022-12-31 | 13G | Mereo BioPharma Group plc MREO | Vivo Capital IX, LLC | 3,761,947 3.100% | -5,647,104![]() (-60.02%) | Filing History |
2023-02-13 1:21 pm Sale | 2022-12-31 | 13G | Mereo BioPharma Group plc MREO | Suvretta Capital Management, LLC | 36,822,190 5.900% | -8,888,145![]() (-19.44%) | Filing History |
2022-10-28 1:17 pm Unchanged | 2022-10-28 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 83,780,600 13.410% | 0 (Unchanged) | Filing History |